Crossmark

Prognostic Differences in Melanoma Between Patients With Locoregional Disease at Initial Diagnosis and Those Who Develop Locoregional Disease After Progression During Follow-Up

Crossref DOI link: https://doi.org/10.1016/j.ad.2025.104517

Published Print: 2026-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Luna, A. https://orcid.org/0000-0002-1196-3174
Alkhawaja, A.

Rizo, D.

Carrera, C.

Malvehy, J.

Puig, S. https://orcid.org/0000-0003-1337-9745
Podlipnik, S. https://orcid.org/0000-0003-4150-0522
Funding

Funding for this research was provided by:

Fundación Científica Asociación Española Contra el Cáncer (GCB15152978SOEN)

European Commission (LSHC-CT-2006-018702)

HORIZON EUROPE Framework Programme (HORIZON-MISS-2021-CANCER-02)

HORIZON EUROPE Framework Programme (101096667)

Agència de Gestió d'Ajuts Universitaris i de Recerca (2017_SGR_1134)

Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares

Seventh Framework Programme

Instituto de Salud Carlos III

Generalitat de Catalunya

Horizon 2020 Framework Programme
License Information

Text and Data Mining valid from 2026-02-01

Text and Data Mining valid from 2026-02-01

Version of Record valid from 2025-12-03
More Information

This article is maintained by: Elsevier

Article Title: Prognostic Differences in Melanoma Between Patients With Locoregional Disease at Initial Diagnosis and Those Who Develop Locoregional Disease After Progression During Follow-Up

Journal Title: Actas Dermo-Sifiliográficas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2025.104517

Content Type: article

Copyright: © 2025 AEDV. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below